In GVHD the functionality of alloreactive T cells was inhibited by targeting NAMPT (22) and similarly, the depletion of NAD+ in T cells via FK866 treatment reduced demyelination in EAE (23, 24). This evidence concerns the gene NAMPT and graft versus host disease.